Protagonist Therapeutics PTGX SEC Filings

NASDAQ PTGX
$146.15 -2.65 (-1.78%)
As of: Sep 4, 2026 · 11:51 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Protagonist Therapeutics, Inc (PTGX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index